U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Reticular hyperpigmentation

MedGen UID:
338832
Concept ID:
C1851972
Finding
Synonym: Reticulate hyperpigmentation
 
HPO: HP:0007588

Definition

Increased pigmentation of the skin with a netlike (reticular) pattern. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVReticular hyperpigmentation

Conditions with this feature

Focal dermal hypoplasia
MedGen UID:
42055
Concept ID:
C0016395
Disease or Syndrome
Focal dermal hypoplasia is a multisystem disorder characterized primarily by involvement of the skin, skeletal system, eyes, and face. Skin manifestations present at birth include atrophic and hypoplastic areas of skin; cutis aplasia; fat nodules in the dermis manifesting as soft, yellow-pink cutaneous nodules; and pigmentary changes. Verrucoid papillomas of the skin and mucous membranes may appear later. The nails can be ridged, dysplastic, or hypoplastic; hair can be sparse or absent. Limb malformations include oligo-/syndactyly and split hand/foot. Developmental abnormalities of the eye can include anophthalmia/microphthalmia, iris and chorioretinal coloboma, and lacrimal duct abnormalities. Craniofacial findings can include facial asymmetry, notched alae nasi, cleft lip and palate, and pointed chin. Occasional findings include dental anomalies, abdominal wall defects, diaphragmatic hernia, and renal anomalies. Psychomotor development is usually normal; some individuals have cognitive impairment.
Naegeli-Franceschetti-Jadassohn syndrome
MedGen UID:
91010
Concept ID:
C0343111
Disease or Syndrome
Naegeli-Franceschetti-Jadassohn syndrome (NFJS) is a rare autosomal dominant disorder of skin, hair, and teeth. It is characterized by complete absence of dermatoglyphics (fingerprint lines), a reticulate pattern of skin hyperpigmentation that tends to disappear with age, thickening of the palms and soles (palmoplantar keratoderma), and decreased sweating. Dental anomalies including enamel defects, skin blistering, and nail dystrophy have been reported in some patients. It can be distinguished from dermatopathia pigmentosa reticularis (DPR) by the latter's features of lifelong persistence of the skin hyperpigmentation, partial alopecia, and absence of dental anomalies (summary by Lugassy et al., 2006).
Dermatopathia pigmentosa reticularis
MedGen UID:
98037
Concept ID:
C0406778
Congenital Abnormality
Dermatopathia pigmentosa reticularis (DPR) is a rare heritable disorder consisting of a triad of cutaneous findings including reticulate hyperpigmentation, noncicatricial alopecia, and onychodystrophy. Variable features include adermatoglyphia, hypohidrosis or hyperhidrosis, and palmoplantar hyperkeratosis (Heimer et al., 1992).
X-linked reticulate pigmentary disorder
MedGen UID:
336844
Concept ID:
C1845050
Disease or Syndrome
X-linked reticulate pigmentary disorder shows more severe manifestations in hemizygous males compared to heterozygous females. Affected males have early onset of recurrent respiratory infections and failure to thrive resulting from inflammatory gastroenteritis or colitis. Patients also show reticular pigmentation abnormalities of the skin and may develop corneal scarring. Carrier females may be unaffected or have only pigmentary abnormalities along the lines of Blaschko (summary by Starokadomskyy et al., 2016).
Dyskeratosis congenita, autosomal recessive 1
MedGen UID:
341705
Concept ID:
C1857144
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
Poikiloderma with neutropenia
MedGen UID:
388129
Concept ID:
C1858723
Disease or Syndrome
Poikiloderma with neutropenia (PN) is characterized by an inflammatory eczematous rash (ages 6-12 months) followed by post-inflammatory poikiloderma (age >2 years) and chronic noncyclic neutropenia typically associated with recurrent sinopulmonary infections in the first two years of life and (often) bronchiectasis. There is increased risk for myelodysplastic syndrome and, rarely, acute myelogenous leukemia. Other ectodermal findings include nail dystrophy and palmar/plantar hyperkeratosis. Most affected individuals also have reactive airway disease and some have short stature, hypogonadotropic hypogonadism, midfacial retrusion, calcinosis cutis, and non-healing skin ulcers.
Dowling-Degos disease 2
MedGen UID:
815477
Concept ID:
C3809147
Disease or Syndrome
Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by reticular pigmentation, usually in a flexural distribution. However, generalized DDD can also occur, with numerous hypopigmented or erythematous macules and papules on the neck, chest, and abdomen. The histopathology of DDD shows characteristic thin branch-like patterns of epidermal downgrowth (summary by Li et al., 2013). Review of Reticulate Pigment Disorders Muller et al. (2012) reviewed the spectrum of reticulate pigment disorders of the skin, tabulating all reported cases of patients with Dowling-Degos disease, reticulate acropigmentation of Kitamura (RAK), reticulate acropigmentation of Dohi (DSH, RAD; 127400), Galli-Galli disease (GGD), and Haber syndrome (HS). Of 82 cases, 26 (31.7%) were clinically diagnosed as DDD, 13 (15.9%) as RAD, 11 (13.4%) as GGD, 8 (9.8%) as RAK, and 8 (9.8%) as HS; in addition, 16 (19.5%) of the cases showed overlap between DDD and RAK. Muller et al. (2012) also published photographs of an affected individual exhibiting an overlap of clinical features of DDD, GGD, RAD, and RAK. The authors noted that in reticulate disorders of the skin, the main disease entity is DDD, with a subset of cases exhibiting acantholysis (GGD), facial erythema (HS), or an acral distribution (RAD; RAK). Muller et al. (2012) concluded that all reticulate pigment diseases of the skin are varying manifestations of a single entity. For a discussion of genetic heterogeneity of reticulate pigment disorders, see 179850.
Dyskeratosis congenita, autosomal dominant 1
MedGen UID:
1645250
Concept ID:
C4551974
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
Bone marrow failure syndrome 5
MedGen UID:
1648380
Concept ID:
C4748488
Disease or Syndrome
Bone marrow failure syndrome-5 (BMFS5) is a hematologic disorder characterized by infantile onset of severe red cell anemia requiring transfusion. Additional features include hypogammaglobulinemia, poor growth with microcephaly, developmental delay, and seizures (summary by Toki et al., 2018) For a discussion of genetic heterogeneity of BMFS, see BMFS1 (614675).
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6
MedGen UID:
1805650
Concept ID:
C5676927
Disease or Syndrome
Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.

Professional guidelines

PubMed

Nakano LC, Cacione DG, Baptista-Silva JC, Flumignan RL
Cochrane Database Syst Rev 2021 Oct 12;10(10):CD012723. doi: 10.1002/14651858.CD012723.pub2. PMID: 34637138Free PMC Article
Biarnés M, Colijn JM, Sousa J, Ferraro LL, Garcia M, Verzijden T, Meester-Smoor MA, Delcourt C, Klaver CCW, den Hollander AI, Lengyel I, Peto T, Monés J; EYE-RISK Consortium
Ophthalmol Retina 2020 Dec;4(12):1129-1137. Epub 2020 May 1 doi: 10.1016/j.oret.2020.04.014. PMID: 32371126
Sadick NS
Am J Clin Dermatol 2003;4(8):545-54. doi: 10.2165/00128071-200304080-00004. PMID: 12862497

Recent clinical studies

Etiology

Atkinson JC, Harvey KE, Domingo DL, Trujillo MI, Guadagnini JP, Gollins S, Giri N, Hart TC, Alter BP
Oral Dis 2008 Jul;14(5):419-27. doi: 10.1111/j.1601-0825.2007.01394.x. PMID: 18938267Free PMC Article
Akoglu G, Boztepe G, Karaduman A
Dermatology 2006;213(4):331-3. doi: 10.1159/000096197. PMID: 17135740
Kopyść Z, Barczyk K, Król E
Hum Genet 1985;70(4):376-8. doi: 10.1007/BF00295380. PMID: 4018802
Graze PR, Gale RP
Am J Med 1979 Apr;66(4):611-20. doi: 10.1016/0002-9343(79)91171-9. PMID: 35001

Diagnosis

Waters J, Desrosiers AS, Flint ND, Ferringer T
Cutis 2023 Oct;112(4):175-199. doi: 10.12788/cutis.0870. PMID: 37988306
Kutlu Ö, Çetinkaya PÖ, Ünverdi H, Vahapoğlu G, Ekşioğlu M
Dermatol Online J 2019 Apr 15;25(4) PMID: 31046910
Winkler JK, Enk AH, Haenssle HA, Toberer F
J Dtsch Dermatol Ges 2019 Feb;17(2):201-204. Epub 2018 Dec 28 doi: 10.1111/ddg.13738. PMID: 30592556
Olsavszky V, Géraud C
J Dtsch Dermatol Ges 2018 Feb;16(2):238-241. Epub 2018 Jan 12 doi: 10.1111/ddg.13419. PMID: 29328527
De Francesco V, Quinkenstein E, Mariuzzi L, Frattasio A, Pillon B, Patrone P
Eur J Dermatol 2006 Mar-Apr;16(2):184-6. PMID: 16581574

Therapy

Winkler JK, Enk AH, Haenssle HA, Toberer F
J Dtsch Dermatol Ges 2019 Feb;17(2):201-204. Epub 2018 Dec 28 doi: 10.1111/ddg.13738. PMID: 30592556
Olsavszky V, Géraud C
J Dtsch Dermatol Ges 2018 Feb;16(2):238-241. Epub 2018 Jan 12 doi: 10.1111/ddg.13419. PMID: 29328527
Melnick L, Castelo-Soccio L
Cutis 2016 Sep;98(3):E4-E5. PMID: 27814415
Riahi RR, Cohen PR
Dermatol Online J 2012 Jun 15;18(6):5. PMID: 22747929
Akoglu G, Boztepe G, Karaduman A
Dermatology 2006;213(4):331-3. doi: 10.1159/000096197. PMID: 17135740

Prognosis

Banerjee S, Chen H, Huang H, Wu J, Yang Z, Deng W, Chen D, Deng J, Su Y, Li Y, Wu C, Wang Y, Zeng H, Wang Y, Li X
Oncotarget 2016 Nov 29;7(48):78363-78371. doi: 10.18632/oncotarget.13279. PMID: 27852057Free PMC Article
Akoglu G, Boztepe G, Karaduman A
Dermatology 2006;213(4):331-3. doi: 10.1159/000096197. PMID: 17135740

Clinical prediction guides

Li M, Cheng R, Liang J, Yan H, Zhang H, Yang L, Li C, Jiao Q, Lu Z, He J, Ji J, Shen Z, Li C, Hao F, Yu H, Yao Z
Am J Hum Genet 2013 Jun 6;92(6):895-903. Epub 2013 May 16 doi: 10.1016/j.ajhg.2013.04.022. PMID: 23684010Free PMC Article
Lee JS, Kossard S, McGrath MA
Arch Dermatol 2008 Sep;144(9):1175-82. doi: 10.1001/archderm.144.9.1175. PMID: 18794463
Akoglu G, Boztepe G, Karaduman A
Dermatology 2006;213(4):331-3. doi: 10.1159/000096197. PMID: 17135740
De Francesco V, Quinkenstein E, Mariuzzi L, Frattasio A, Pillon B, Patrone P
Eur J Dermatol 2006 Mar-Apr;16(2):184-6. PMID: 16581574
Graze PR, Gale RP
Am J Med 1979 Apr;66(4):611-20. doi: 10.1016/0002-9343(79)91171-9. PMID: 35001

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...